Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
Healthcare
$29.36 +0.00%
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
52W Low $4.30High $31.70
Volume 0.00M
Average 0.87M
Income Statement
Follow revenue through to earnings.
Revenue
$6.22M
FY 2024 · Annual
+3.4% YoYOperating Income
$1.39M
FY 2024 · Annual
+37.7% YoYNet Income
$1.20M
FY 2024 · Annual
+54.2% YoYIncome Statement
USD
Metric | FY2022 Mar 2023 | FY2023 Mar 2024 | FY2024 Mar 2025 |
|---|---|---|---|
| Revenue | 3.53M | 6.02M | 6.22M |
| Cost of Revenue | 2.04M | 2.1M | 2.04M |
| Gross Profit | 1.49M | 3.91M | 4.18M |
| Gross Margin | 42.3% | 65.1% | 67.2% |
| Research & Development | 0 | 0 | 0 |
| Selling, General & Admin | 1.66M | 2.35M | 2.32M |
| Operating Expenses | 2.02M | 2.91M | 2.79M |
| Depreciation & Amortization | 211.08K | 391.7K | 263.45K |
| EBITDA | (189.13K) | 1.42M | 1.72M |
| EBITDA Margin | -5.4% | 23.6% | 27.6% |
| Operating Income | (521.34K) | 1.01M | 1.39M |
| Operating Margin | -14.8% | 16.8% | 22.3% |
| Interest Income | 10.29K | 19.51K | 64.14K |
| Interest Expense | 20.26K | 26.05K | 20.87K |
| Other Income / Expenses | 100.87K | (5.35K) | 46.23K |
| Income Before Tax | (420.47K) | 1M | 1.44M |
| Pre-Tax Margin | -11.9% | 16.7% | 23.1% |
| Income Tax Expense | (84.86K) | 181.75K | 236.08K |
| Net Income | (305.12K) | 777.81K | 1.2M |
| Net Margin | -8.6% | 12.9% | 19.3% |
| EPS (Basic) | (0.02) | 0.05 | 0.07 |
| EPS (Diluted) | (0.02) | 0.05 | 0.07 |
| 16.94M | 16.94M | 16.94M | |
| 16.94M | 16.94M | 16.94M |
MCTA Earnings Waterfall · TTM
NASDAQ:MCTA · Revenue to Net Income
No earnings data available.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Sep 29, 2026 | |
| 20-F | 20-F filing | Jul 30, 2026 | |
| 6-K | 6-K filing | Jul 21, 2026 | |
| 6-K | 6-K filing | May 6, 2026 | |
| 6-K | 6-K filing | Apr 2, 2026 |
How much revenue does MCTA generate?
Charming Medical Limited Class A Ordinary Shares (MCTA) reported $6.22M of revenue in fiscal 2024.
Is MCTA profitable?
Charming Medical Limited Class A Ordinary Shares (MCTA) reported $1.20M of net income, with a net margin of 19.3%.
Continue the stock analysis
Jump to another research area for this company.